Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,809
Closed -$49.5K 3308
2023
Q1
$49.5K Buy
2,809
+2,153
+328% +$111K ﹤0.01% 2756
2022
Q4
$34.1K Buy
656
+246
+60% +$17.9K ﹤0.01% 2634
2022
Q3
$34K Buy
+410
New +$54.4K ﹤0.01% 2346
2022
Q2
Sell
-9,734
Closed -$1.5M 3004
2022
Q1
$1.5M Buy
9,734
+2,416
+33% +$537K ﹤0.01% 1489
2021
Q4
$2.01M Buy
7,318
+6,277
+603% +$2.9M ﹤0.01% 1912
2021
Q3
$680K Buy
+1,041
New +$916K ﹤0.01% 2986

Other funds holding NEUE

John Overdeck's NEUE Position: Q2 2023 in Review

John Overdeck sold out of NeueHealth (NEUE) in Q2 2023, closing a stake of 2,809 shares — an estimated $49.5K sold.

John Overdeck first reported a position in NEUE in Q3 2021 and held it in 6 quarters. The position peaked at $2.01M in Q4 2021. 49 funds tracked by Wall St. Rank hold NEUE as of Q2 2023.

  • John Overdeck reported no remaining NeueHealth position as of Q2 2023 after selling out during the quarter.
  • John Overdeck sold 2,809 NeueHealth shares in Q2 2023, an estimated $49.5K.
  • John Overdeck first reported a position in NeueHealth in Q3 2021 and held it in 6 quarters.
  • John Overdeck's NeueHealth position peaked at $2.01M in Q4 2021.
  • 49 funds tracked by Wall St. Rank held NeueHealth as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.